Table 2.
Patient Characteristics by Global Self-Efficacy Score at Baseline and Treatment Week 24.
| Characteristic | Baseline Global Self-Efficacy Score (N=384) | Week 24 Global Self-Efficacy Score (N=170) | ||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| n | % | Median (IQR) | p-value | n | % | Median (IQR) | p-value | |
| Gender | 0.079 | 0.316 | ||||||
| Male | 248 | 66 | 8.8 (7.7–9.6) | 101 | 59 | 8.4 (7.1–9.4) | ||
| Female | 136 | 34 | 8.5 (7.8–9.3) | 69 | 41 | 8.1 (6.7–9.2) | ||
| Race | 0.768 | 0.393 | ||||||
| AA | 183 | 48 | 8.7 (7.8–9.5) | 65 | 38 | 8.4 (7.2–9.4) | ||
| CA | 201 | 52 | 8.7 (7.7–9.4) | 105 | 62 | 8.2 (6.7–9.2) | ||
| Marital Status* | <0.001 | 0.003 | ||||||
| Married/Relationship | 186 | 48 | 9.0 (8.1–9.7) | 80 | 48 | 8.4 (7.7–9.5) | ||
| Never Married | 71 | 19 | 8.2 (7.5–9.2) | 29 | 18 | 8.2 (7.1–9.1) | ||
| Divorced/Widow/Separated | 127 | 33 | 8.6 (7.5–9.2) | 57 | 34 | 7.5 (6.5–9.1) | ||
| Education Level* | 0.043 | 0.461 | ||||||
| < High School | 69 | 18 | 8.4 (7.4–9.4) | 30 | 18 | 7.7 (6.6–9.4) | ||
| ≥ High School | 314 | 82 | 8.8 (7.9–9.5) | 135 | 82 | 8.3 (7.0–9.2) | ||
| Employment Status* | <0.001 | <0.001 | ||||||
| Employed | 245 | 64 | 8.9 (8.2–9.6) | 104 | 63 | 8.5 (7.4–9.4) | ||
| Unemployed | 139 | 36 | 8.3 (7.6–9.3) | 62 | 37 | 7.5 (6.5–8.5) | ||
| Insurance* | <0.001 | 0.028 | ||||||
| Private | 230 | 60 | 8.9 (8.2–9.6) | 90 | 55 | 8.5 (7.4–9.4) | ||
| Public | 85 | 22 | 8.2 (7.5–9.2) | 34 | 21 | 7.4 (6.5–8.4) | ||
| Uninsured | 67 | 18 | 8.4 (7.3–9.1) | 40 | 24 | 8.1 (6.6–9.0) | ||
Note: IQR: Interquartile Range. Self-efficacy scores range from 0–10, with higher scores indicative of higher self-efficacy.
*
Sample sizes may not sum to overall N. Three level post-hoc pairwise comparisons analyzed using Kruskal-Wallis test with a Bonferroni correction for multiple comparisons set at 0.05/3=0.0167.